BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26321084)

  • 1. Practice innovation: the need for nimble data platforms to implement precision oncology care.
    Elfiky A; Zhang D; Krishnan Nair HK
    Discov Med; 2015; 20(108):27-32. PubMed ID: 26321084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
    Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
    Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Systems Understanding to Personalized Medicine: Lessons and Recommendations Based on a Multidisciplinary and Translational Analysis of COPD.
    Roca J; Cano I; Gomez-Cabrero D; Tegnér J
    Methods Mol Biol; 2016; 1386():283-303. PubMed ID: 26677188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network science in clinical trials: A patient-centered approach.
    Manem VSK; Salgado R; Aftimos P; Sotiriou C; Haibe-Kains B
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):135-150. PubMed ID: 29278737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partnering with patients in translational oncology research: ethical approach.
    Mamzer MF; Duchange N; Darquy S; Marvanne P; Rambaud C; Marsico G; Cerisey C; Scotté F; Burgun A; Badoual C; Laurent-Puig P; Hervé C
    J Transl Med; 2017 Apr; 15(1):74. PubMed ID: 28390420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge bases and software support for variant interpretation in precision oncology.
    Borchert F; Mock A; Tomczak A; Hügel J; Alkarkoukly S; Knurr A; Volckmar AL; Stenzinger A; Schirmacher P; Debus J; Jäger D; Longerich T; Fröhling S; Eils R; Bougatf N; Sax U; Schapranow MP
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33971666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing customization in health care: a framework derived from the services sector literature.
    Minvielle E; Waelli M; Sicotte C; Kimberly JR
    Health Policy; 2014 Aug; 117(2):216-27. PubMed ID: 24837516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating predictive biomarkers within oncology clinical development programs.
    Beckman RA; Chen C
    Biomark Med; 2015; 9(9):851-62. PubMed ID: 26330133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The forthcoming era of precision medicine.
    Gamulin S
    Acta Med Acad; 2016 Nov; 45(2):152-157. PubMed ID: 28000491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support.
    Chae YK; Pan AP; Davis AA; Patel SP; Carneiro BA; Kurzrock R; Giles FJ
    Mol Cancer Ther; 2017 Dec; 16(12):2645-2655. PubMed ID: 29203694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Needs and Challenges for Radiation Oncology in the Era of Precision Medicine.
    Quon H; McNutt T; Lee J; Bowers M; Jiang W; Lakshminarayanan P; Cheng Z; Han P; Hui X; Shah V; Moore J; Nakatsugawa M; Robertson S; Cecil E; Page B; Kiess A; Wong J; DeWeese T
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):809-817. PubMed ID: 30562547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
    Mousses S; Kiefer J; Von Hoff D; Trent J
    Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Medicine: What's in it for Rare Diseases?
    Schee Genannt Halfmann S; Mählmann L; Leyens L; Reumann M; Brand A
    Adv Exp Med Biol; 2017; 1031():387-404. PubMed ID: 29214584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scotland's Knowledge Network: translating knowledge into action to improve quality of care.
    Wales A; Graham S; Rooney K; Crawford A
    Scott Med J; 2012 Nov; 57(4):221-4. PubMed ID: 23138580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
    Ersek JL; Black LJ; Thompson MA; Kim ES
    Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century.
    Calvo F; Apolone G; Baumann M; Caldas C; Celis JE; de Lorenzo F; Ernberg I; Ringborg U; Rowell J; Tabernero J; Voest E; Eggermont A
    Eur J Cancer; 2018 Nov; 103():155-159. PubMed ID: 30241002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse avatars of human cancers: the temporality of translation in precision oncology.
    Green S; Dam MS; Svendsen MN
    Hist Philos Life Sci; 2021 Feb; 43(1):27. PubMed ID: 33620596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Care and Personalized or Precision Medicine: Who needs whom?
    Sugeir S; Naylor S
    J Crit Care; 2018 Feb; 43():401-405. PubMed ID: 29174462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.